News|Articles|November 14, 2023 (Updated: November 17, 2023)
Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More
Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.
Advertisement
Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Opinion: US Biodefense Policy Under Scrutiny as NIH, CDC Pandemic Preparedness Programs Face Cuts
2
Building a Bridge Between the OR and Central Sterile Processing Improves On Time Starts at New York Presbyterian
3
Shared Imperiatives: Diagnostic Excellence, EMR Nudges, and Smarter Testing Strategies
4
Cepheid Selected by CDC as National Collaborator to Accelerate Rapid Diagnostic Development for Future Pandemics
5